AAPL349.81+5.98 (+1.74%) ▲|ABBV288.72+2.73 (+0.95%) ▲|ABT103.72+1.08 (+1.05%) ▲|ACN246.26+2.86 (+1.18%) ▲|ADBE247.48-2.28 (-0.91%) ▼|AMAT423.89+7.89 (+1.90%) ▲|AMD564.68-13.76 (-2.38%) ▼|AMGN458.62+6.79 (+1.50%) ▲|AMT185.35+1.60 (+0.87%) ▲|AMZN244.78-9.82 (-3.86%) ▼|AVGO344.60-7.21 (-2.05%) ▼|AXP323.85+5.91 (+1.86%) ▲|BA172.66+5.52 (+3.30%) ▲|BAC51.36+0.51 (+0.99%) ▲|BKNG149.26+1.32 (+0.89%) ▲|BLK1,167.49+9.61 (+0.83%) ▲|BMY60.34-0.24 (-0.39%) ▼|BNY149.22+0.63 (+0.42%) ▲|BRK-B543.76+3.42 (+0.63%) ▲|C125.35+1.24 (+1.00%) ▲|CAT646.56-66.82 (-9.37%) ▼|CL92.66+0.97 (+1.06%) ▲|CMCSA22.03+0.46 (+2.11%) ▲|COF208.38+3.50 (+1.71%) ▲|COP149.74+0.68 (+0.46%) ▲|COST992.41+9.68 (+0.98%) ▲|CRM231.39-10.72 (-4.43%) ▼|CSCO108.59-1.70 (-1.54%) ▼|CVS89.61-0.34 (-0.38%) ▼|CVX230.85+1.65 (+0.72%) ▲|DE657.20+16.53 (+2.58%) ▲|DHR234.76+0.69 (+0.29%) ▲|DIS110.84+1.80 (+1.65%) ▲|DUK125.67+2.10 (+1.70%) ▲|EMR169.81+2.10 (+1.25%) ▲|FDX307.07+2.49 (+0.82%) ▲|GD369.16+14.81 (+4.18%) ▲|GE311.05+9.92 (+3.29%) ▲|GEV889.06+11.03 (+1.26%) ▲|GILD161.32+2.12 (+1.33%) ▲|GM85.33+2.85 (+3.45%) ▲|GOOG279.85-42.04 (-13.06%) ▼|GOOGL281.79-43.11 (-13.27%) ▼|GS927.10+1.93 (+0.21%) ▲|HD325.63+8.07 (+2.54%) ▲|HON221.89+2.63 (+1.20%) ▲|IBM255.40+2.18 (+0.86%) ▲|INTC91.33-4.20 (-4.40%) ▼|INTU329.97+1.78 (+0.54%) ▲|ISRG448.52+4.34 (+0.98%) ▲|JNJ274.09+3.05 (+1.13%) ▲|JPM342.57+3.27 (+0.96%) ▲|KO92.46+0.73 (+0.79%) ▲|LIN499.84-8.32 (-1.64%) ▼|LLY1,371.02+82.72 (+6.42%) ▲|LMT646.44+16.69 (+2.65%) ▲|LOW204.43+6.03 (+3.04%) ▲|LRCX257.50+3.68 (+1.45%) ▲|MA635.83+25.52 (+4.18%) ▲|MCD255.36+4.86 (+1.94%) ▲|MDLZ62.09+0.22 (+0.36%) ▲|MDT96.78+2.00 (+2.11%) ▲|META629.89+17.40 (+2.84%) ▲|MMM176.37+3.57 (+2.07%) ▲|MO75.57+2.58 (+3.53%) ▲|MRK147.55+6.62 (+4.70%) ▲|MS192.58+2.45 (+1.29%) ▲|MSFT524.03-6.99 (-1.32%) ▼|MU945.99-37.24 (-3.79%) ▼|NEE82.20+1.18 (+1.46%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.39+1.24 (+3.32%) ▲|NOW112.01-38.12 (-25.39%) ▼|NVDA213.52-1.87 (-0.87%) ▼|ORCL139.64-4.91 (-3.39%) ▼|PEP132.93+0.30 (+0.23%) ▲|PFE29.73+0.28 (+0.94%) ▲|PG159.01+0.75 (+0.47%) ▲|PLTR194.55-2.27 (-1.15%) ▼|PM205.74+3.10 (+1.53%) ▲|QCOM183.24+0.27 (+0.15%) ▲|RTX200.65+4.81 (+2.45%) ▲|SBUX104.56+1.36 (+1.32%) ▲|SCHW89.72+0.96 (+1.08%) ▲|SO93.07+1.55 (+1.69%) ▲|SPG214.71+3.47 (+1.64%) ▲|T21.03+0.33 (+1.59%) ▲|TMO709.33+5.18 (+0.74%) ▲|TMUS148.77+0.69 (+0.47%) ▲|TSLA405.89+1.67 (+0.41%) ▲|TXN309.48-0.35 (-0.11%) ▼|UBER65.29+0.02 (+0.02%) ▲|UNH405.79-1.31 (-0.32%) ▼|UNP299.08+1.28 (+0.43%) ▲|UPS106.50+0.88 (+0.83%) ▲|USB60.65+1.05 (+1.76%) ▲|V409.94+9.34 (+2.33%) ▲|VZ43.70+0.52 (+1.19%) ▲|WFC85.09+1.42 (+1.69%) ▲|WMT121.05+2.28 (+1.92%) ▲|XOM182.01-0.01 (-0.01%) ▼|AAPL349.81+5.98 (+1.74%) ▲|ABBV288.72+2.73 (+0.95%) ▲|ABT103.72+1.08 (+1.05%) ▲|ACN246.26+2.86 (+1.18%) ▲|ADBE247.48-2.28 (-0.91%) ▼|AMAT423.89+7.89 (+1.90%) ▲|AMD564.68-13.76 (-2.38%) ▼|AMGN458.62+6.79 (+1.50%) ▲|AMT185.35+1.60 (+0.87%) ▲|AMZN244.78-9.82 (-3.86%) ▼|AVGO344.60-7.21 (-2.05%) ▼|AXP323.85+5.91 (+1.86%) ▲|BA172.66+5.52 (+3.30%) ▲|BAC51.36+0.51 (+0.99%) ▲|BKNG149.26+1.32 (+0.89%) ▲|BLK1,167.49+9.61 (+0.83%) ▲|BMY60.34-0.24 (-0.39%) ▼|BNY149.22+0.63 (+0.42%) ▲|BRK-B543.76+3.42 (+0.63%) ▲|C125.35+1.24 (+1.00%) ▲|CAT646.56-66.82 (-9.37%) ▼|CL92.66+0.97 (+1.06%) ▲|CMCSA22.03+0.46 (+2.11%) ▲|COF208.38+3.50 (+1.71%) ▲|COP149.74+0.68 (+0.46%) ▲|COST992.41+9.68 (+0.98%) ▲|CRM231.39-10.72 (-4.43%) ▼|CSCO108.59-1.70 (-1.54%) ▼|CVS89.61-0.34 (-0.38%) ▼|CVX230.85+1.65 (+0.72%) ▲|DE657.20+16.53 (+2.58%) ▲|DHR234.76+0.69 (+0.29%) ▲|DIS110.84+1.80 (+1.65%) ▲|DUK125.67+2.10 (+1.70%) ▲|EMR169.81+2.10 (+1.25%) ▲|FDX307.07+2.49 (+0.82%) ▲|GD369.16+14.81 (+4.18%) ▲|GE311.05+9.92 (+3.29%) ▲|GEV889.06+11.03 (+1.26%) ▲|GILD161.32+2.12 (+1.33%) ▲|GM85.33+2.85 (+3.45%) ▲|GOOG279.85-42.04 (-13.06%) ▼|GOOGL281.79-43.11 (-13.27%) ▼|GS927.10+1.93 (+0.21%) ▲|HD325.63+8.07 (+2.54%) ▲|HON221.89+2.63 (+1.20%) ▲|IBM255.40+2.18 (+0.86%) ▲|INTC91.33-4.20 (-4.40%) ▼|INTU329.97+1.78 (+0.54%) ▲|ISRG448.52+4.34 (+0.98%) ▲|JNJ274.09+3.05 (+1.13%) ▲|JPM342.57+3.27 (+0.96%) ▲|KO92.46+0.73 (+0.79%) ▲|LIN499.84-8.32 (-1.64%) ▼|LLY1,371.02+82.72 (+6.42%) ▲|LMT646.44+16.69 (+2.65%) ▲|LOW204.43+6.03 (+3.04%) ▲|LRCX257.50+3.68 (+1.45%) ▲|MA635.83+25.52 (+4.18%) ▲|MCD255.36+4.86 (+1.94%) ▲|MDLZ62.09+0.22 (+0.36%) ▲|MDT96.78+2.00 (+2.11%) ▲|META629.89+17.40 (+2.84%) ▲|MMM176.37+3.57 (+2.07%) ▲|MO75.57+2.58 (+3.53%) ▲|MRK147.55+6.62 (+4.70%) ▲|MS192.58+2.45 (+1.29%) ▲|MSFT524.03-6.99 (-1.32%) ▼|MU945.99-37.24 (-3.79%) ▼|NEE82.20+1.18 (+1.46%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.39+1.24 (+3.32%) ▲|NOW112.01-38.12 (-25.39%) ▼|NVDA213.52-1.87 (-0.87%) ▼|ORCL139.64-4.91 (-3.39%) ▼|PEP132.93+0.30 (+0.23%) ▲|PFE29.73+0.28 (+0.94%) ▲|PG159.01+0.75 (+0.47%) ▲|PLTR194.55-2.27 (-1.15%) ▼|PM205.74+3.10 (+1.53%) ▲|QCOM183.24+0.27 (+0.15%) ▲|RTX200.65+4.81 (+2.45%) ▲|SBUX104.56+1.36 (+1.32%) ▲|SCHW89.72+0.96 (+1.08%) ▲|SO93.07+1.55 (+1.69%) ▲|SPG214.71+3.47 (+1.64%) ▲|T21.03+0.33 (+1.59%) ▲|TMO709.33+5.18 (+0.74%) ▲|TMUS148.77+0.69 (+0.47%) ▲|TSLA405.89+1.67 (+0.41%) ▲|TXN309.48-0.35 (-0.11%) ▼|UBER65.29+0.02 (+0.02%) ▲|UNH405.79-1.31 (-0.32%) ▼|UNP299.08+1.28 (+0.43%) ▲|UPS106.50+0.88 (+0.83%) ▲|USB60.65+1.05 (+1.76%) ▲|V409.94+9.34 (+2.33%) ▲|VZ43.70+0.52 (+1.19%) ▲|WFC85.09+1.42 (+1.69%) ▲|WMT121.05+2.28 (+1.92%) ▲|XOM182.01-0.01 (-0.01%) ▼|
17.5 C
New York
Thursday, October 29, 2026

Tag: lawsuit

newsFORsourcecompanycontentinformationreleases1market

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance Biotherapeutics, Inc.(IOVA) Shareholders

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) of a class action securities lawsuit.

CAR FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline.

Napco (NSSC) Under Scrutiny: Investor Suit and Sales Slump Shake Investor Confidence – Hagens Berman

NSSC Investors with Losses Encouraged to Contact Hagens Berman Before June 24th Deadline in Securities Class Action 
NSSC Investors with Losses Encouraged to Contact Hagens Berman Before June 24th Deadline in Securities Class Action

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025.

CODI SHAREHOLDERS: Compass Diversified Holdings Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 8 Deadline (NYSE:CODI)

Compass Diversified Holdings investors that lost money are notified to contact BFA Law before July 8, 2025 securities fraud class action deadline.

ELV SHAREHOLDERS: Elevance Health, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 11 Deadline (NYSE:ELV)

Elevance Health, Inc. investors that lost money are notified to contact BFA Law before July 11, 2025 securities fraud class action deadline.

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bitfarms Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BITF

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. (NASDAQ: BITF) between March 21, 2023 and December 9, 2024, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline.

CIVI SHAREHOLDERS: Civitas Resources, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 1 Deadline (NYSE:CIVI)

Civitas Resources, Inc. investors that lost money are notified to contact BFA Law before July 1, 2025 securities fraud class action deadline.

URGN SHAREHOLDERS: UroGen Pharma Ltd. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 28 Deadline (NASDAQ:URGN)

UroGen Pharma Ltd. investors that lost money are notified to contact BFA Law before July 28, 2025 securities fraud class action deadline.

OGN SHAREHOLDERS: Organon & Co. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 22 Deadline (NYSE:OGN)

Organon & Co. investors that lost money are notified to contact BFA Law before July 22, 2025 securities fraud class action deadline.

IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before July 14, 2025 securities fraud class action deadline.

FTRE SHAREHOLDERS: Fortrea Holdings Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by August 1 Deadline (NASDAQ:FTRE)

Fortrea Holdings Inc. investors that lost money are notified to contact BFA Law before August 1, 2025 securities fraud class action deadline.

Congress Pretends to Care About Privacy. Again.

23andMe, the genetic testing firm that promised to revolutionize personal genomics, is on the auction block. After years of financial struggles, a bankruptcy filing...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLawsuit

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers